Johnson & Johnson to delay COVID-19 vaccine rollout in Europe
CGTN
Share
Copied
The Johnson & Johnson laboratory announced on Tuesday that it will delay the deployment of its vaccine in Europe after the U.S. health authorities had recommended a "pause" in the use of this vaccine over blood clots concerns.